ETP 12.5 Tablet 7 pcs

ETP tablet is indicated for-

• Treatment of thrombocytopenia in patients with persistent or chronic immune thrombocytopenia.
• Treatment of thrombocytopenia in patients with hepatitis C infection.
• Treatment of severe aplastic anemia.

Limitations of use: ETP tablet is not indicated for the treatment of patients with myelodysplastic syndromes (MDS). Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for the treatment of chronic hepatitis C infection.